Sertaconazole

Pregnancy Category: C

Lactation: not known if distributed into milk; use caution

Pregnancy Categories

A:Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

B:May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

C:Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

D:Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

X:Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

NA:Information not available.

Sertaconazole is part of the drug class:

• Imidazole and triazole derivatives

• If you have an allergy to sertaconazole or any other part of sertaconazole.
• If you are allergic to any drugs like this one, any other drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.

This medicine may interact with other drugs or health problems.

Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. You must check to make sure that it is safe for you to take this medicine with all of your drugs and health problems. Do not start, stop, or change the dose of any drug without checking with your doctor.

• Sertaconazole Nitrate

• Antifungal Agent, Imidazole Derivative
• Antifungal Agent, Topical

Tinea pedis: Topical: Apply between toes and to surrounding healthy skin twice daily for 4 weeks

Cutaneous candidiasis (off-label use): Topical: Apply to affected area(s) twice daily for 4 weeks (Alomar 1992)

Seborrheic dermatitis (off-label use): Topical: Apply to affected area(s) twice daily for 4 weeks (Goldust 2013)

Tinea versicolor (off-label use): Topical: Apply to affected area(s) twice daily for 4 weeks (Nasarre 1992). Additional data may be necessary to further define the role of sertaconazole in this condition.

Store at 20°C to 25°C (68°F to 77°F); excursions are permitted between 15°C and 30°C (59°F and 86°F).

1% to 10%: Dermatologic: Burning sensation of skin, contact dermatitis, skin tenderness, xeroderma

<1% (Limited to important or life-threatening): Desquamation, erythema, hyperpigmentation, pruritus, skin vesicle